Frequently
asked
questions
Not an actual patient.
What is Enzyvant CONNECT®?
Enzyvant CONNECT is a program that helps children with congenital athymia and their caregivers by providing personalized support throughout the treatment journey. The Enzyvant CONNECT care team consists of a Support Liaison and an Access Specialist, who can:
- Provide you with educational resources about congenital athymia and treatment
- Determine insurance coverage and out-of-pocket costs if you have a commercial plan, Medicare, or Medicaid
- Insurance coverage and costs will be annually reverified
- Identify and put you in touch with other patient assistance resources that may provide financial support
Enrolling in Enzyvant CONNECT will also give you access to kits containing a document organizer, storybook written specifically with your child in mind, activities for the whole family, and more! You will also receive informative digital newsletters and access to a webinar series.
How do patients and caregivers enroll in Enzyvant CONNECT?
To begin the enrollment process for Enzyvant CONNECT, you can call 844-ENZCNCT ( 844-369-2628) or complete the enrollment form with the help of your child's healthcare provider.
Alternatively, your child's healthcare provider can fill out the enrollment form to enroll them in Enzyvant CONNECT. Follow the instructions on the form to complete it and send it back to Enzyvant CONNECT.
How do you protect the personal information that is submitted on the Patient Enrollment Form?
Privacy is important to us. To effectively work with the healthcare provider’s office on issues such as verifying insurance benefits and other needs, Enzyvant CONNECT will need to access some of your child’s personal health information, information about you (their parent/guardian), insurance coverage, and other confidential information. Enzyvant CONNECT handles personal health information in compliance with applicable laws and regulations, including HIPAA, and only for the purposes stated on the Patient Enrollment Form.
Once I’m enrolled in Enzyvant CONNECT, does this mean my child is next for treatment?
Sumitomo Pharma America, Inc. does not make treatment decisions and enrollment does not have any impact on when your child will be treated. Your child’s healthcare provider and the team at Duke University Health System will determine if your child is eligible for treatment. If your child is eligible for treatment, your healthcare provider will discuss with you the timing of treatment.
Once enrolled in Enzyvant CONNECT, what support and assistance programs are available to patients and caregivers?
The Enzyvant CONNECT care team consists of a Support Liaison and an Access Specialist, who can:
- Provide you with educational resources about congenital athymia and treatment
- Determine insurance coverage and out-of-pocket costs if you have a commercial plan, Medicare, or Medicaid
- Insurance coverage and costs will be annually reverified
- Identify and put you in touch with other patient assistance resources that may provide financial support
Enrolling in Enzyvant CONNECT will also give you access to kits containing a document organizer, storybook written specifically with your child in mind, activities for the whole family, and more! You will also receive informative digital newsletters and access to a webinar series.
Is treatment available to uninsured or underinsured patients?
An Access Specialist can connect caregivers with financial assistance programs and charitable organizations that may help uninsured or underinsured patients.
Does my income impact my child's ability to receive treatment?
No, your income has no bearing on treatment decisions. The decision for treatment is made with your treating physician and the team at the treatment center.